Metraipolis › archive › dc_5985528a855f

Adjuvant capecitabine in women with triple-negative breast cancer with residual disease after carboplatin-containing neoadjuvant chemotherapy — Europe PMC PMID:41910838

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41910838
DOI
10.1007/s10549-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-03T16:41:02.140Z
SHA-256 of the archived text
14324f499dd47f18cb2a833ca31a26ddef58d8dd2686403f2cd5a6ac9bd93169
Stable URL of this page
https://metraipolis.com/documento/dc_5985528a855f

How to cite

Adjuvant capecitabine in women with triple-negative breast cancer with residual disease after carboplatin-containing neoadjuvant chemotherapy — Europe PMC PMID:41910838 — Europe PMC (en), https://europepmc.org/article/MED/41910838 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5985528a855f (Metraipolis archive dc_5985528a855f, sha256 14324f499dd47f18cb2a833ca31a26ddef58d8dd2686403f2cd5a6ac9bd93169)
BibTeX
@misc{dc5985528a855f,
  title = {Adjuvant capecitabine in women with triple-negative breast cancer with residual disease after carboplatin-containing neoadjuvant chemotherapy — Europe PMC PMID:41910838},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41910838},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5985528a855f; sha256 14324f499dd47f18cb2a833ca31a26ddef58d8dd2686403f2cd5a6ac9bd93169},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41910838. Agents can read the archived copy with the MCP tool read_document.